SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

RBC Cuts Perspective Therapeutics to Sector Perform, Lowers Target to $4

RBC cut its rating from Outperform to Sector Perform and reduced its price target from $14 to $4.

CATX

Story updates

10:28:55 AM UTC
SquawkNews
06:28 AM EDT, 10/26/2026 (MT Newswires) -- Perspective Therapeutics (CATX) has an average rating of

Related stories